The expression of HDAC2 was significantly reduced in the asthma model group (p < 0.0001), was downregulated in Dex-treated mice (p < 0.01) and was restored by Dex and further potentiated by R406 treatment (p < 0.0001). Here, HDAC2 is linked to asthma.